Alpha 2.0
Login Register
» Articles » PMID: 39583422

Tissue Plasminogen Activator (tPA) Use in Persistent Loculated Ascites

Overview
Journal Cureus
Specialty Biomedical Engineering
Date 2024 Nov 25
PMID 39583422
Authors
Komail Mujtaba Ali
Rhett Molloy
Alexander Friedman
Wichit Srikureja
Christopher Bent
Roger C Garrison
Affiliations
Soon will be listed here.
Abstract

Spontaneous bacterial peritonitis (SBP) complicated by loculated ascites presents a therapeutic challenge, particularly when standard of care or surgical intervention is not feasible. This case report documents the successful use of intraperitoneal tissue plasminogen activator (tPA) as adjunctive salvage therapy in an adult female with decompensated liver cirrhosis and loculated infected ascites. After no improvement in the patient's clinical condition following 14 days of intravenous antibiotics, catheter-directed intraperitoneal tPA was administered for three days, resulting in the improvement of her abdominal pain and resolution of the loculations. This case provides additional support for the potential efficacy of tPA as salvage therapy in managing loculated infected ascites in cirrhotic patients who have failed standard treatments.

References
1.
Rimola A, Garcia-Tsao G, Navasa M, Piddock L, Planas R, Bernard B . Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000; 32(1):142-53. DOI: 10.1016/s0168-8278(00)80201-9. View
2.
Alkhero M, Patel A, De Silva S . Role of Tissue Plasminogen Activator in Loculated Ascites. ACG Case Rep J. 2021; 8(5):e00590. PMC: 8169073. DOI: 10.14309/crj.0000000000000590. View
3.
Piccolo F, Pitman N, Bhatnagar R, Popowicz N, Smith N, Brockway B . Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc. 2014; 11(9):1419-25. DOI: 10.1513/AnnalsATS.201407-329OC. View
4.
Rahman N, Maskell N, West A, Teoh R, Arnold A, Mackinlay C . Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011; 365(6):518-26. DOI: 10.1056/NEJMoa1012740. View
5.
Tripon S, Mayer P, Svab A, Habersetzer F, Pessaux P, Baumert T . Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis. Clin Res Hepatol Gastroenterol. 2020; 45(2):101486. DOI: 10.1016/j.clinre.2020.06.012. View